Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 29.84% is in line with its 5-year average of 28.60%, near the high end of its 5-year range (10.97%–32.26%).
8.27% above its 12-month average of 27.56%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 27.42%.
EBITDA MARGIN
29.84%
EBITDA MARGIN AVG TTM
27.56%
EBITDA MARGIN AVG 3Y
28.85%
EBITDA MARGIN AVG 5Y
28.60%
EBITDA MARGIN AVG 10Y
27.83%
EBITDA MARGIN AVG 15Y
28.45%
EBITDA MARGIN AVG 20Y
29.54%
CURRENT VS TTM AVG
+8.27%
CURRENT VS 3Y AVG
+3.43%
CURRENT VS 5Y AVG
+4.35%
CURRENT VS 10Y AVG
+7.23%
CURRENT VS 15Y AVG
+4.87%
CURRENT VS 20Y AVG
+1.02%
Zimmer Biomet Holdings, Inc.
Market Cap
$18.45B
EBITDA Margin
29.84%
TTM Avg
27.56%
3Y Avg
28.85%
5Y Avg
28.60%
Market Cap
$17.09B
EBITDA Margin
22.25%
TTM Avg
22.41%
3Y Avg
21.18%
5Y Avg
20.68%
Market Cap
$21.00B
EBITDA Margin
50.36%
TTM Avg
50.37%
3Y Avg
51.80%
5Y Avg
47.75%
Market Cap
$15.38B
EBITDA Margin
32.07%
TTM Avg
25.68%
3Y Avg
26.69%
5Y Avg
27.49%
Market Cap
$13.64B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.45B | 29.84% | 27.56% | 28.85% | 28.60% |
| Viatris Inc. (VTRS)vs › | $19.74B | 0.95% | 10.32% | 17.98% | 18.96% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | 22.25% | 22.41% | 21.18% | 20.68% |
| STERIS plc (STE)vs › | $19.98B | 26.76% | 25.68% | 26.35% | 25.75% |
| Revvity, Inc. (RVTY)vs › | $16.00B | 23.07% | 26.75% | 30.05% | 32.80% |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 50.36% | 50.37% | 51.80% | 47.75% |
| Solventum Corporation (SOLV)vs › | $15.38B | 32.07% | 25.68% | 26.69% | 27.49% |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 38.84% | 34.03% | 26.26% | 22.70% |
| Tempus AI, Inc. (TEM)vs › | $13.64B | -11.84% | -53.07% | -52.51% | -64.32% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.39B | 22.69% | 18.62% | 20.95% | 21.80% |
Gross Margin
61.6%
EBITDA Margin
29.8%
Operating Margin
15.7%
Net Margin
9.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 27.42% |
| 2026-03-31 | 25.65% |
| 2025-12-31 | 25.48% |
| 2025-09-30 | 31.72% |
| 2025-06-30 | 27.53% |
| 2025-03-31 | 28.64% |
| 2024-12-31 | 32.26% |
| 2024-09-30 | 29.08% |
| 2024-06-30 | 30.61% |
| 2024-03-31 | 26.70% |
| 2023-12-31 | 30.69% |
| 2023-09-30 | 28.96% |
| 2023-06-30 | 30.33% |
| 2023-03-31 | 30.54% |
| 2022-12-31 | 10.97% |
| 2022-09-30 | 28.55% |
| 2022-06-30 | 28.82% |
| 2022-03-31 | 25.99% |
| 2021-12-31 | 16.99% |
| 2021-09-30 | 28.24% |
| 2021-06-30 | 26.12% |
| 2021-03-31 | 30.87% |
| 2020-12-31 | 24.27% |
| 2020-09-30 | 28.91% |
| 2020-06-30 | 6.85% |
| 2020-03-31 | -11.38% |
| 2019-12-31 | 27.79% |
| 2019-09-30 | 26.28% |
| 2019-06-30 | 23.02% |
| 2019-03-31 | 30.27% |
| 2018-12-31 | -25.87% |
| 2018-09-30 | 26.35% |
| 2018-06-30 | 27.77% |
| 2018-03-31 | 28.18% |
| 2017-12-31 | 10.92% |
| 2017-09-30 | 26.35% |
| 2017-06-30 | 27.91% |
| 2017-03-31 | 31.22% |
| 2016-12-31 | 21.62% |
| 2016-09-30 | 26.39% |
| 2016-06-30 | 23.47% |
| 2016-03-31 | 25.86% |
| 2015-12-31 | 25.74% |
| 2015-09-30 | 20.17% |
| 2015-06-30 | -2.78% |
| 2015-03-31 | 31.64% |
| 2014-12-31 | 26.04% |
| 2014-09-30 | 31.29% |
| 2014-06-30 | 29.77% |
| 2014-03-31 | 34.53% |
| 2013-12-31 | 32.68% |
| 2013-09-30 | 28.26% |
| 2013-06-30 | 25.81% |
| 2013-03-31 | 33.66% |
| 2012-12-31 | 24.63% |
| 2012-09-30 | 32.38% |
| 2012-06-30 | 35.14% |
| 2012-03-31 | 34.40% |
| 2011-12-31 | 25.31% |
| 2011-09-30 | 34.66% |
| 2011-06-30 | 30.57% |
| 2011-03-31 | 34.36% |
| 2010-12-31 | 18.82% |
| 2010-09-30 | 36.82% |
| 2010-06-30 | 29.21% |
| 2010-03-31 | 35.66% |
| 2009-12-31 | 29.47% |
| 2009-09-30 | 29.95% |
| 2009-06-30 | 37.09% |
| 2009-03-31 | 36.21% |
| 2008-12-31 | 30.95% |
| 2008-09-30 | 29.10% |
| 2008-06-30 | 34.81% |
| 2008-03-31 | 37.14% |
| 2007-12-31 | 38.59% |
| 2007-09-30 | 20.39% |
| 2007-06-30 | 39.00% |
| 2007-03-31 | 40.05% |
| 2006-12-31 | 41.87% |
| 2006-09-30 | 37.30% |
| 2006-06-30 | 37.34% |
| 2006-03-31 | 39.13% |
| 2005-12-31 | 38.98% |
| 2005-09-30 | 37.53% |
| 2005-06-30 | 37.92% |
| 2005-03-31 | 36.54% |
| 2004-12-31 | 35.99% |
| 2004-09-30 | 34.18% |
| 2004-06-30 | 30.02% |
| 2004-03-31 | 26.34% |
| 2003-12-31 | 15.12% |
| 2003-09-30 | 37.62% |
| 2003-06-30 | 38.07% |
| 2003-03-31 | 36.30% |
| 2002-12-31 | 31.79% |
| 2002-09-30 | 30.96% |
